Cost-Effectiveness Of Rivaroxaban Compared With Real-World Treatment For Stroke Prevention In Non-Valvular Atrial Fibrillation In China
Abstract
Authors
L Yang J Wu
L Yang J Wu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now